- Home
- POAI vs HOTH Comparison
POAI vs HOTH Comparison
Compare POAI & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- HOTH
- Stock Information
- Founded
- POAI 2002
- HOTH 2017
- Country
- POAI United States
- HOTH United States
- Employees
- POAI N/A
- HOTH 3
- Industry
- POAI Industrial Specialties
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- POAI Health Care
- HOTH Health Care
- Exchange
- POAI Nasdaq
- HOTH Nasdaq
- Market Cap
- POAI 8.9M
- HOTH 16.0M
- IPO Year
- POAI N/A
- HOTH 2019
- Fundamental
- Price
- POAI $0.79
- HOTH $1.44
- Analyst Decision
- POAI Hold
- HOTH Strong Buy
- Analyst Count
- POAI 1
- HOTH 3
- Target Price
- POAI N/A
- HOTH $4.00
- AVG Volume (30 Days)
- POAI 158.5K
- HOTH 733.2K
- Earning Date
- POAI 08-12-2025
- HOTH 05-12-2025
- Dividend Yield
- POAI N/A
- HOTH N/A
- EPS Growth
- POAI N/A
- HOTH N/A
- EPS
- POAI N/A
- HOTH N/A
- Revenue
- POAI $1,729,269.00
- HOTH N/A
- Revenue This Year
- POAI $486.27
- HOTH N/A
- Revenue Next Year
- POAI $65.50
- HOTH N/A
- P/E Ratio
- POAI N/A
- HOTH N/A
- Revenue Growth
- POAI 24.17
- HOTH N/A
- 52 Week Low
- POAI $0.55
- HOTH $0.58
- 52 Week High
- POAI $3.06
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- POAI 33.09
- HOTH 62.68
- Support Level
- POAI $0.73
- HOTH $1.17
- Resistance Level
- POAI $0.86
- HOTH $1.34
- Average True Range (ATR)
- POAI 0.05
- HOTH 0.10
- MACD
- POAI -0.00
- HOTH 0.02
- Stochastic Oscillator
- POAI 38.43
- HOTH 77.27
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).